Toward defining the autoimmune microbiome for type 1 diabetes

Area of Science:

• Microbiome research
• Immunology
• Pediatric autoimmunity

Background:

• Gut bacteria influence diabetes in animal models.
• The role of human gut microbes in type 1 diabetes (T1D) autoimmunity is not fully understood.
• T1D involves the autoimmune destruction of insulin-producing pancreatic islet cells.

Purpose of the Study:

• To investigate the association between human intestinal microbes and the development of T1D-associated autoimmunity in at-risk children.
• To identify potential bacterial biomarkers for early T1D diagnosis and prevention.

Main Methods:

• Utilized high-throughput, culture-independent sequencing techniques.
• Compared gut microbial composition and diversity in young children at high genetic risk for T1D, differentiating between those who developed autoimmunity and age/genotype-matched controls.
• Analyzed longitudinal changes in the microbiome over time.

Main Results:

• Identified specific bacteria correlating with T1D autoimmunity development.
• Observed diminished bacterial diversity over time in autoimmune subjects compared to non-autoimmune controls.
• Noted significant shifts in specific bacterial species, such as an increase in Bacteroides ovatus in cases and a specific firmicute strain (CO19) in controls.
• Evidence suggests a less diverse and stable microbiome in children progressing towards autoimmunity.

Conclusions:

• The autoimmune microbiome in T1D may differ significantly from that of healthy children.
• Gut bacteria composition and diversity changes are associated with T1D autoimmunity development.
• Identified potential bacterial markers for early T1D diagnosis and suggested that certain bacteria could be leveraged for preventing autoimmunity in high-risk children.